Oasmia Pharmaceutical Presentation at RedChip's April 2016 Conference

May. 2, 2016
Oasmia Pharmaceutical AB (“Oasmia,” “OASM,” or the “Company) develops new cancer drugs for use in humans and animals. The Company's technology is a ...

 Read More


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market